Postmenopausal bleeding (PMB) is a common presenting symptom of pelvic malignancy, and endometrial cancer in particular. In 1984, diagnostic curettage (D&C) was performed upon 293 patients for PMB at The Jessop Hospital. Forty-four (15%) of these patients had an endometrial cancer.
Many of the patients referred with PMB are elderly and have additional medical problems, such as diabetes mellitus, hypertension and obesity. Indeed, this combination of problems is associated with endometrial carcinoma and is sometimes referred to as the 'corpus cancer syndrome'. These conditions and their sequelae of coronary and other arterial disease make such patients poor anaesthetic risks. They also increase the time of inpatient stay (average length of stay at the Jessop Hospital was 4 days).
Current diagnostic methods
In majority of patients (75%), no serious abnormality is found as a result of examination under anaesthetic and curettage, and so the interest in detecting endometrial tumours without anaesthetic has developed. Cervical Hysterography and hysteroscopy have also been used in diagnosis, but both ofthese techniques require some experience and expertise when used in outpatients.
An encouraging paper from Raju and Taylor on the use of hysteroscopy shows the advantages of direct vision in locating tumours, particularly solitary lesions which can be missed at curettage5. This technique seems to be extremely accurate in diagnosing tumours and other endometrial abnormalities. In the reported series, only 10 out of 70 patients did not have a general anaesthetic, and the potential for the use of this instrument in outpatients is good. Patient discomfort is the limiting factor for most of these techniques although most patients will tolerate these procedures well. To use the hysteroscope, there must be an opening of reasonable diameter into the endometrial canal, but there are a substantial number of postmenopausal patients in whom the cervix is too stenosed, or has been amputated, making the passage of the instrument difficult or impossible even under general anaesthetic. It is in these cases that I feel there is a substantive role for ultrasound or perhaps other non-invasive imaging modalities. An alternative might also be nuclear magnetic resonance scanning, which has been used to estimate the depth of invastion of endometrial tumours6. However, this method is costly and not presently available to the average practitioner.
Practicality of pelvic ultrasound Pelvic ultrasound examination using modern high resolution equipment may be a useful technique for detecting pelvic malignancy. Interestingly, it has been research on infertility that has led to the development of both uterine and ovarian scanning. The use of ultrasound screening ofthe ovaries has already been evaluated by Goswamy and colleagues7. Their aim was the early detection and treatment of ovarian cancer, thus improving the survival rates from this disease. The incidence of abnormal ovarian morphology in their series was only 3% (34 out of 1084 patients). The low prevalence of the disease, therefore, limits the practicality of such screening.
High resolution real time ultrasound can also be used to measure the thickness of the endometrium8. This has been used to monitor oestrogen production as a bioassay, in patients undergoing induction of ovulation or puberty. The prepubertal uterus has been compared anatomically in size with the postmenopausal uterus and neither should contain any endometrial echoes. Administration of exogenous or stimulation of endogenous oestrogens promotes growth of the uterine cross-sectional area on sagittal section when measured ultrasonically9.
In the postmenopausal patient the endometrial canal can be demonstrated but should contain no endometrial or fluid echoes. Thus, provided the cavity can be seen clearly, it should be possible to exclude all but the tiniest tumours. If any echoes are found or fluid areas seen, curettage is mandatory.
At the same time as scanning the uterus, the ovaries can be examined and the outline of the bladder checked. Unfortunately only advanced bladder tumours are likely to be detected in this way. A recent study at the Jessop Hospital in which an ultrasound of the pelvis was performed on 60 patients with PMB who were admitted for D & C has shown promise. Six endometrial cancers were diagnosed and, more importantly, no tumours were missed by the scan. Indeed two bladder tumours and one ovarian cancer were also picked up which were not clinically suspected. Using the transabdominal route about 15% of patients could not be scanned because of an inability to create or maintain a full enough bladder; catheterization can reduce this figure. The use of newer vaginal probes is also promising. Three patients in this study had undergone Manchester repairs and attempted curettage had failed; hysterectomy subequent to abnormal findings on ultrasound confirmed the presence of abnormalities.
A further study and similar findings by Nasri favour the use of ultrasound as a diagnostic tool in such patients'0. It can be used to reduce the number of patients requiring an anaesthetic and D & C, diagnose related sites of malignancy and exclude intrauterine tumours in patients we are unable to curette.
There may also be a place, when the cervical os is accessible, for combining scanning and the use of a biopsy curette to make the initial definitive diagnosis, rather than submitting patients to an anaesthetic. In these days of cost cutting, outpatient management may give benefits to the patient and the budget.
